Kenji Uéda

3.7k total citations
65 papers, 3.0k citations indexed

About

Kenji Uéda is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kenji Uéda has authored 65 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Neurology, 33 papers in Physiology and 24 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kenji Uéda's work include Parkinson's Disease Mechanisms and Treatments (42 papers), Alzheimer's disease research and treatments (33 papers) and Neurological disorders and treatments (9 papers). Kenji Uéda is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (42 papers), Alzheimer's disease research and treatments (33 papers) and Neurological disorders and treatments (9 papers). Kenji Uéda collaborates with scholars based in Japan, China and United States. Kenji Uéda's co-authors include Piu Chan, Shun Yu, Kunimasa Arima, Eizo Iseki, Wami Marui, Yoko Izumiyama, Kenji Kosaka, Nobuo Yamashita, Mitsuru Kawai and N Sunohara and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Kenji Uéda

65 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Uéda Japan 33 1.9k 1.3k 1.1k 654 518 65 3.0k
Akihiko Iwai Japan 16 2.4k 1.3× 1.9k 1.5× 1.3k 1.2× 784 1.2× 529 1.0× 38 3.5k
Christopher E. Ellis United States 6 1.4k 0.7× 751 0.6× 751 0.7× 614 0.9× 279 0.5× 7 2.2k
Masaaki Waragai Japan 30 1.2k 0.6× 1.0k 0.8× 765 0.7× 1.0k 1.6× 466 0.9× 85 3.0k
Claire Henchcliffe United States 30 1.6k 0.8× 503 0.4× 910 0.8× 1.2k 1.8× 345 0.7× 70 3.3k
Latha Devi United States 19 735 0.4× 1.6k 1.3× 900 0.8× 1.3k 2.0× 394 0.8× 19 3.0k
Susan E. Daniel United Kingdom 23 4.3k 2.2× 1.2k 1.0× 1.7k 1.6× 1.2k 1.8× 991 1.9× 34 5.9k
Susan Leight United States 19 1.5k 0.8× 2.2k 1.8× 953 0.9× 1.2k 1.8× 795 1.5× 21 3.9k
Marı́a José Casarejos Spain 32 1.1k 0.6× 662 0.5× 1.1k 1.0× 983 1.5× 519 1.0× 76 2.9k
Sigurlaug Sveinbjörnsdóttir Iceland 18 1.8k 0.9× 496 0.4× 975 0.9× 691 1.1× 536 1.0× 21 3.0k
Richard J. Perrin United States 29 1.4k 0.7× 1.7k 1.3× 554 0.5× 922 1.4× 694 1.3× 81 3.7k

Countries citing papers authored by Kenji Uéda

Since Specialization
Citations

This map shows the geographic impact of Kenji Uéda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Uéda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Uéda more than expected).

Fields of papers citing papers by Kenji Uéda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Uéda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Uéda. The network helps show where Kenji Uéda may publish in the future.

Co-authorship network of co-authors of Kenji Uéda

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Uéda. A scholar is included among the top collaborators of Kenji Uéda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Uéda. Kenji Uéda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuwa, Masahiro, et al.. (2016). Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination. PLoS ONE. 11(7). e0158797–e0158797. 8 indexed citations
2.
Shimazaki, Atsushi, et al.. (2015). Benefits of Tafluprost and Timolol Fixed-Dose Combination for the Treatment of Glaucoma Are Confirmed by Studies on Experimental Animal Models. Journal of Ocular Pharmacology and Therapeutics. 31(9). 518–524. 3 indexed citations
3.
Zhou, Ming, et al.. (2013). Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress. Brain Research. 1500. 19–27. 34 indexed citations
4.
Duan, Chunli, Lu Li, Hua Gao, et al.. (2011). α-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator. The International Journal of Biochemistry & Cell Biology. 43(5). 732–741. 53 indexed citations
5.
Uéda, Kenji, et al.. (2011). Melatonin reduces the expression of alpha‐synuclein in the dopamine containing neuronal regions of amphetamine‐treated postnatal rats. Journal of Pineal Research. 52(1). 128–137. 26 indexed citations
6.
Qi, Xuan, Shengli Xu, Dehong Lu, et al.. (2011). Increase expression of α-synuclein in aged human brain associated with neuromelanin accumulation. Journal of Neural Transmission. 118(11). 1575–1583. 33 indexed citations
7.
Cheng, Furong, Xin Li, Yaohua Li, et al.. (2011). α‐Synuclein promotes clathrin‐mediated NMDA receptor endocytosis and attenuates NMDA‐induced dopaminergic cell death. Journal of Neurochemistry. 119(4). 815–825. 62 indexed citations
8.
Liu, Guangwei, Chunyan Zhang, Xin Li, et al.. (2009). α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neuroscience Letters. 454(3). 187–192. 160 indexed citations
9.
Fukushima, Hotaka, Ryouta Maeda, Akinobu Suzuki, et al.. (2008). Upregulation of Calcium/Calmodulin-Dependent Protein Kinase IV Improves Memory Formation and Rescues Memory Loss with Aging. Journal of Neuroscience. 28(40). 9910–9919. 110 indexed citations
10.
11.
Kojima, Masaki, et al.. (2007). Observation of multiple intermediates in α-synuclein fibril formation by singular value decomposition analysis. Biochemical and Biophysical Research Communications. 355(2). 398–403. 27 indexed citations
12.
Terada, Seishi, Hideki Ishizu, Osamu Yokota, et al.. (2003). Glial involvement in diffuse Lewy body disease. Acta Neuropathologica. 105(2). 163–169. 54 indexed citations
13.
Yokota, Osamu, Seishi Terada, Hideki Ishizu, et al.. (2002). NACP/α-Synuclein, NAC, and β-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases. Acta Neuropathologica. 104(6). 637–648. 36 indexed citations
14.
Yokota, Osamu, Seishi Terada, Hideki Ishizu, et al.. (2002). NACP/α-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC). Acta Neuropathologica. 104(4). 333–341. 32 indexed citations
15.
16.
Togo, Takashi, Eizo Iseki, Wami Marui, et al.. (2001). Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies. Journal of the Neurological Sciences. 184(1). 71–75. 52 indexed citations
17.
Iseki, Eizo, Wami Marui, Kenji Kosaka, & Kenji Uéda. (1999). Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neuroscience Letters. 265(1). 9–12. 60 indexed citations
18.
Arima, Kunimasa, Shigeo Hirai, N Sunohara, et al.. (1999). Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Brain Research. 843(1-2). 53–61. 171 indexed citations
19.
Arima, Kunimasa, Kenji Uéda, N Sunohara, et al.. (1998). Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Research. 808(1). 93–100. 216 indexed citations
20.
Ishimaru, Hirohisa, Kenji Uéda, Akira Takahashi, & Yūji Maruyama. (1998). Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus. Brain Research. 788(1-2). 311–314. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiko Iwai Breakdown of academic impact, for papers by Christopher E. Ellis Breakdown of academic impact, for papers by Masaaki Waragai Breakdown of academic impact, for papers by Claire Henchcliffe Breakdown of academic impact, for papers by Latha Devi Breakdown of academic impact, for papers by Susan E. Daniel Breakdown of academic impact, for papers by Susan Leight Breakdown of academic impact, for papers by Marı́a José Casarejos Breakdown of academic impact, for papers by Sigurlaug Sveinbjörnsdóttir Breakdown of academic impact, for papers by Richard J. Perrin
Rankless by CCL
2026